查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2151938

出血性中風治療設備市場規模、佔有率和趨勢分析報告：按治療類型、最終用途、地區和細分市場分類（2026-2033 年）

Hemorrhagic Stroke Treatment Devices Market Size, Share & Trends Analysis Report By Treatment Type, By End-use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

用於治療出血性中風的醫療器材市場概況

預計到 2025 年，全球用於治療出血性中風的器械市場價值將達到 19 億美元，到 2026 年將成長到 20 億美元，到 2033 年將成長到 31 億美元，2026 年至 2033 年的年複合成長率（CAGR）為 6.2%。

北美市場領先，預計到 2025 年將佔據最大的銷售佔有率，達到 43.8%。推動這一行業發展的因素是腦出血和腦動脈瘤發病率的上升，尤其是在老年人和高血壓患者中。

腦出血和腦動脈瘤發生率的上升導致需要緊急醫療干預的患者數量增加，這直接推動了對治療出血性中風器械的需求。隨著確診病例的增多，醫療專業人員正在採用先進的血管內和微創技術來改善治療效果，這促進了市場成長，並刺激了治療方案的持續創新和投資。

許多歐洲國家仍然面臨嚴重的出血性中風負擔，這有助於市場的擴張。

根據世界卒中組織發布的《2025年全球卒中概況》，每年新增卒中病例超過1200萬例，這意味著全球近四分之一的人一生中會經歷卒中。該報告強調了出血性中風的沉重負擔，其中腦出血（ICH）佔所有中風病例的28.8%，蛛網膜下腔出血（SAH）佔5.8%。預計在預測期內，該疾病盛行率的不斷上升將成為市場成長的主要驅動力。

根據美國心臟協會（AHA）2022年2月發布的數據，出血性中風約占美國每年報告的約80萬例中風病例的10%，且與其他類型中風相比，其死亡率更高。這種嚴重的疾病負擔預計將推動對治療出血性中風所需設備的需求。

在預測期內，對微創治療策略（例如早期微創清除腦出血和內視鏡血腫清除）的日益關注預計將成為市場成長的主要驅動力。正在進行的臨床試驗正在推動相關技術的研發，以提高手術安全性和臨床療效。例如，NICO公司於2024年4月發表了ENRICH（早期微創清除腦出血）臨床試驗的正面結果。這些結果表明，使用該公司BrainPath和Myriad系統進行的早期微創細胞旁手術（MIPS）安全有效，並且與目前腦出血的標準治療方法——基於指南的藥物治療相比，療效更佳。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章 出血性中風治療器械市場：變數、趨勢和範圍

  • 市場譜系展望
  • 市場動態
  • 用於治療出血性中風的醫療器材市場分析工具

第4章 出血性中風治療設備市場：依治療類型分類的估算與趨勢分析

  • 全球出血性中風治療設備市場：按治療類型分類的趨勢分析（2025 年和 2033 年）
  • 全球出血性中風治療設備市場：按治療類型分類的市場規模和趨勢分析（2021-2033年）
  • 動脈瘤和出血性中風的介入治療
    • 適應症
    • 透過裝置
  • 用於輔助性治療和血管痙攣管理的裝置
    • 用於治療血管痙攣的球囊血管成形術系統
    • 線圈輔助輔助裝置（球囊輔助和支架輔助）
  • 輔助和手術通道設備
    • 引導管和遠端通路導管
    • 微導管
    • 檢修鞘套和電線

第5章 出血性中風治療設備市場：依最終用途分類的估算與趨勢分析

  • 全球出血性中風治療設備市場：按最終用途分類的趨勢分析（2025 年和 2033 年）
  • 全球出血性中風治療設備市場：按最終用途分類的規模和趨勢分析（2021-2033年）
  • 醫院
  • 專業神經外科中心
  • 門診手術中心

第6章 出血性中風治療器材市場：區域估算與趨勢分析

  • 區域儀錶板
  • 市場規模及趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 丹麥
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特

第7章 競爭情勢

  • 主要市場參與企業的最新趨勢及影響分析
  • 公司分類
  • 企業市場占有率分析，2025 年
  • 企業熱力圖分析
  • 策略規劃
    • 業務拓展
    • 併購
    • 夥伴關係與合作
    • 引入新的治療方法
    • 研究與開發
    • 公司簡介
    • Medtronic
    • MicroVention公司（Terumo Corporation）
    • Balt
    • Scientia Vascular, Inc.
    • MicroPort Scientific Corporation
    • 強生公司（醫療技術）
    • phenox GmbH（Wallaby Medical）
    • Acandis GmbH
    • B. Braun SE
    • Integra 生命科學
    • Infinity Neuro LLC
    • Penumbra, Inc.
    • 波士頓科學公司
    • 前鋒
    • Peter LAZIC GmbH
Product Code: GVR-4-68040-841-5

Hemorrhagic Stroke Treatment Devices Market Summary

The global hemorrhagic stroke treatment devices market size was valued at USD 1.9 billion in 2025 and is projected to grow from USD 2.0 billion in 2026 to USD 3.1 billion by 2033, at a CAGR of 6.2% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 43.8% in 2025. The industry is driven by the rising incidence of intracerebral hemorrhage and cerebral aneurysms, particularly among aging populations and patients with hypertension.

The rising incidence of intracerebral hemorrhage and cerebral aneurysms increases the number of patients requiring urgent medical intervention, directly boosting demand for hemorrhagic stroke treatment devices. As more cases are diagnosed, healthcare providers adopt advanced endovascular and minimally invasive technologies to improve outcomes, which in turn drives market growth and encourages continued innovation and investment in treatment solutions.

Multiple countries across Europe continue to report a significant hemorrhagic stroke burden, contributing to anticipated market expansion.

According to the Global Stroke Fact Sheet 2025 published by the World Stroke Organization, more than 12 million new stroke cases occur annually, and nearly one in four people worldwide will experience a stroke during their lifetime. The report indicates that intracerebral hemorrhage (ICH) accounts for 28.8% and subarachnoid hemorrhage (SAH) for 5.8% of all incident strokes, underscoring the substantial hemorrhagic stroke burden. The growing prevalence of this disease is expected to be a key driver of market growth during the forecast period.

According to data published by the American Heart Association in February 2022, hemorrhagic strokes account for approximately 10% of the nearly 800,000 stroke cases reported annually in the U.S., and they are associated with a higher mortality rate compared to other stroke types. This considerable disease burden is anticipated to drive demand for hemorrhagic stroke treatment devices.

The increasing focus on minimally invasive treatment strategies, including early minimally invasive evacuation of intracerebral hemorrhage (ICH) and endoscopic hematoma removal, is expected to be a key driver of market growth over the forecast period. Ongoing clinical trials are supporting the development of technologies that improve procedural safety and clinical outcomes. For example, in April 2024, NICO Corporation reported positive results from the ENRICH (Early MiNimally-invasive Removal of ICH) clinical trial, showing that early minimally invasive parafascicular surgery (MIPS) using its BrainPath and Myriad systems was safe and demonstrated superior outcomes compared with guideline-based medical management alone, the current standard of care for ICH.

Global Hemorrhagic Stroke Treatment Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global hemorrhagic stroke treatment devices market report on the basis of treatment type, end-use, and region:

  • Treatment Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Aneurysm & Hemorrhagic Stroke Interventions
    • By Indication
    • Intracranial Aneurysm
    • cSDH (MMA Embolization)
    • AVM & AVF Embolization
    • By Device
    • Embolization Coiling Systems
    • Bare Platinum Coils
    • Coated / Bioactive Coils
    • Flow Diversion Systems
    • Standard Flow-Diverting Stents (e.g., Pipeline)
    • Next-Generation / Surface-Modified Flow Diverters
    • Intrasaccular Flow Disruption Devices
    • Woven EndoBridge (WEB)
    • Contour Neurovascular System
    • Luna Aneurysm Embolization System
    • Liquid Embolization Agents
    • Non-Adhesive Liquid Embolics (Onyx, Squid, PHIL)
    • Adhesive Liquid Embolics (NBCA)
  • Adjunctive & Vasospasm Management Devices
    • Vasospasm Balloon Angioplasty Systems
    • Coil-Assisted Adjunctive Devices (Balloon-assisted and stent-assisted)
  • Ancillary & Procedural Access Devices
    • Guiding & Distal Access Catheters
    • Microcatheters
    • Access Sheaths & Wires
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Specialty Neurosurgery Centers
  • Ambulatory Surgical Centers
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Treatment Type
    • 1.1.2. End Use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
  • 1.5. Details of primary research
    • 1.5.1. Data for primary interviews in North America
    • 1.5.2. Data for primary interviews in Europe
    • 1.5.3. Data for primary interviews in Asia Pacific
    • 1.5.4. Data for primary interviews in Latin America
    • 1.5.5. Data for Primary interviews in MEA
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
      • 1.7.1.1. Approach 1: Commodity flow approach
    • 1.7.2. Volume price analysis (Model 2)
      • 1.7.2.1. Approach 2: Volume price analysis
  • 1.8. Research Scope and Assumptions
    • 1.8.1. List of Secondary Sources
    • 1.8.2. List of Primary Sources
    • 1.8.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Hemorrhagic Stroke Treatment Devices Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Rising prevalence of intracranial aneurysms and hemorrhagic stroke
      • 3.2.1.2. Advancements in neurointerventional technologies
      • 3.2.1.3. Growing adoption of endovascular procedures
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. High cost of devices and procedures
      • 3.2.2.2. Limited availability of skilled neurointerventional specialists
    • 3.2.3. Market Opportunity Analysis
      • 3.2.3.1. Technological innovation in minimally invasive neurointerventional devices
      • 3.2.3.2. Rising public awareness about hemorrhagic stroke
      • 3.2.3.3. Increasing clinical trials
      • 3.2.3.4. Expansion of stroke care infrastructure in emerging markets
      • 3.2.3.5. Rising stroke incidence among younger adults
    • 3.2.4. Market Challenge Analysis
      • 3.2.4.1. Complications associated with neurovascular treatments
      • 3.2.4.2. Balancing innovation with safety requirements
  • 3.3. Hemorrhagic Stroke Treatment Devices Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal landscape

Chapter 4. Hemorrhagic Stroke Treatment Devices Market: Treatment Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Hemorrhagic Stroke Treatment Devices Market: Treatment Type Movement Analysis, 2025 & 2033 (USD Million)
  • 4.3. Global Hemorrhagic Stroke Treatment Devices Market Size & Trend Analysis, by Treatment Type, 2021 to 2033 (USD Million)
  • 4.4. Aneurysm & Hemorrhagic Stroke Interventions
    • 4.4.1. Aneurysm & hemorrhagic stroke interventions market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. By indication
      • 4.4.2.1. By indication market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.2.2. Intracranial aneurysm
        • 4.4.2.2.1. Intracranial aneurysm market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.2.3. cSDH (MMA Embolization)
        • 4.4.2.3.1. cSDH (MMA Embolization) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.2.4. AVM & AVF embolization
        • 4.4.2.4.1. AVM & AVF embolization market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. By device
      • 4.4.3.1. By device market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.2. Embolization coiling systems
        • 4.4.3.2.1. Embolization coiling systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.4.3.2.2. Bare Platinum Coils
          • 4.4.3.2.2.1. Bare Platinum Coils market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.4.3.2.3. Coated / Bioactive Coils
          • 4.4.3.2.3.1. Coated / Bioactive Coils market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.3. Flow diversion systems
        • 4.4.3.3.1. Flow diversion systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.4.3.3.2. Standard Flow-Diverting Stents (e.g., Pipeline)
          • 4.4.3.3.2.1. Standard Flow-Diverting Stents (e.g., Pipeline) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.4.3.3.3. Next-Generation / Surface-Modified Flow Diverters
          • 4.4.3.3.3.1. Next-Generation / Surface-Modified Flow Diverters market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.4. Intrasaccular flow disruption devices
        • 4.4.3.4.1. Intrasaccular flow disruption devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.4.3.4.2. Woven EndoBridge (WEB)
          • 4.4.3.4.2.1. Woven EndoBridge (WEB) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.4.3.4.3. Contour Neurovascular System
          • 4.4.3.4.3.1. Contour Neurovascular System market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.4.3.4.4. Luna Aneurysm Embolization System
          • 4.4.3.4.4.1. Luna Aneurysm Embolization System market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.5. Liquid embolization agents
        • 4.4.3.5.1. Liquid embolization agents market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.4.3.5.2. Non-Adhesive Liquid Embolics (Onyx, Squid, PHIL)
          • 4.4.3.5.2.1. Non-Adhesive Liquid Embolics (Onyx, Squid, PHIL) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.4.3.5.3. Adhesive Liquid Embolics (NBCA)
          • 4.4.3.5.3.1. Adhesive Liquid Embolics (NBCA) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5. Adjunctive & Vasospasm Management Devices
    • 4.5.1. Vasospasm Balloon Angioplasty Systems
      • 4.6.3.1. Vasospasm balloon angioplasty systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.2. Coil-assisted adjunctive devices (Balloon-assisted and stent-assisted)
      • 4.6.4.1. Coil-assisted adjunctive devices (Balloon-assisted and stent-assisted) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.6. Ancillary & procedural access devices
    • 4.6.1. Ancillary & procedural access devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.6.2. Guiding & distal access catheters
      • 4.7.2.1. Guiding & distal access catheters market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.6.3. Microcatheters
      • 4.7.3.1. Microcatheters market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.6.4. Access sheaths & wires
      • 4.7.4.1. Access sheaths & wires market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Hemorrhagic Stroke Treatment Devices Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Hemorrhagic Stroke Treatment Devices Market: End use Movement Analysis, 2025 & 2033 (USD Million)
  • 5.3. Global Hemorrhagic Stroke Treatment Devices Market Size & Trend Analysis, by End use 2021 to 2033 (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5. Specialty Neurosurgery Centers
    • 5.5.1. Specialty neurosurgery centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.6. Ambulatory Surgical Centers
    • 5.6.1. Ambulatory surgical centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Hemorrhagic Stroke Treatment Devices Market: Regional Estimates & Trend Analysis by Treatment Type, and End Use

  • 6.1. Regional Dashboard
  • 6.2. Market Size and Trend Analysis, 2021 to 2033
  • 6.3. North America
    • 6.3.1. North America hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Competitive scenario
      • 6.3.2.3. Regulatory framework
      • 6.3.2.4. Reimbursement scenario
      • 6.3.2.5. U.S. hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Competitive scenario
      • 6.3.3.3. Regulatory framework
      • 6.3.3.4. Reimbursement scenario
      • 6.3.3.5. Canada hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.3.4. Mexico
      • 6.3.4.1. Key country dynamics
      • 6.3.4.2. Competitive scenario
      • 6.3.4.3. Regulatory framework
      • 6.3.4.4. Reimbursement scenario
      • 6.3.4.5. Mexico hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.4. Europe
    • 6.4.1. Europe hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.4.2. UK
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Competitive scenario
      • 6.4.2.3. Regulatory framework
      • 6.4.2.4. Reimbursement scenario
      • 6.4.2.5. UK hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Germany
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Competitive scenario
      • 6.4.3.3. Regulatory framework
      • 6.4.3.4. Reimbursement scenario
      • 6.4.3.5. Germany hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.4.4. France
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Competitive scenario
      • 6.4.4.3. Regulatory framework
      • 6.4.4.4. Reimbursement scenario
      • 6.4.4.5. France hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Competitive scenario
      • 6.4.5.3. Regulatory framework
      • 6.4.5.4. Reimbursement scenario
      • 6.4.5.5. Italy hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Competitive scenario
      • 6.4.6.3. Regulatory framework
      • 6.4.6.4. Reimbursement scenario
      • 6.4.6.5. Spain hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Competitive scenario
      • 6.4.7.3. Regulatory framework
      • 6.4.7.4. Reimbursement scenario
      • 6.4.7.5. Sweden hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Competitive scenario
      • 6.4.8.3. Regulatory framework
      • 6.4.8.4. Reimbursement scenario
      • 6.4.8.5. Denmark hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.4.9. Norway
      • 6.4.9.1. Key country dynamics
      • 6.4.9.2. Competitive scenario
      • 6.4.9.3. Regulatory framework
      • 6.4.9.4. Reimbursement scenario
      • 6.4.9.5. Norway hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Asia Pacific hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Competitive scenario
      • 6.5.2.3. Regulatory framework
      • 6.5.2.4. Reimbursement scenario
      • 6.5.2.5. China hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.5.3. Japan
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Competitive scenario
      • 6.5.3.3. Regulatory framework
      • 6.5.3.4. Reimbursement scenario
      • 6.5.3.5. Japan hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.5.4. India
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Competitive scenario
      • 6.5.4.3. Regulatory framework
      • 6.5.4.4. Reimbursement scenario
      • 6.5.4.5. India hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.5.5. South Korea
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Competitive scenario
      • 6.5.5.3. Regulatory framework
      • 6.5.5.4. Reimbursement scenario
      • 6.5.5.5. South Korea hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.5.6. Australia
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Competitive scenario
      • 6.5.6.3. Regulatory framework
      • 6.5.6.4. Reimbursement scenario
      • 6.5.6.5. Australia hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.5.7. Thailand
      • 6.5.7.1. Key country dynamics
      • 6.5.7.2. Competitive scenario
      • 6.5.7.3. Regulatory framework
      • 6.5.7.4. Reimbursement scenario
      • 6.5.7.5. Thailand hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Latin America hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Competitive scenario
      • 6.6.2.3. Regulatory framework
      • 6.6.2.4. Reimbursement scenario
      • 6.6.2.5. Brazil hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Competitive scenario
      • 6.6.3.3. Regulatory framework
      • 6.6.3.4. Reimbursement scenario
      • 6.6.3.5. Argentina hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.7. Middle East and Africa
    • 6.7.1. Middle East and Africa hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Competitive scenario
      • 6.7.2.3. Regulatory framework
      • 6.7.2.4. Reimbursement scenario
      • 6.7.2.5. South Africa hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.7.3. Saudi Arabia
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Competitive scenario
      • 6.7.3.3. Regulatory framework
      • 6.7.3.4. Reimbursement scenario
      • 6.7.3.5. Saudi Arabia hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Competitive scenario
      • 6.7.4.3. Regulatory framework
      • 6.7.4.4. Reimbursement scenario
      • 6.7.4.5. UAE hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Competitive scenario
      • 6.7.5.3. Regulatory framework
      • 6.7.5.4. Reimbursement scenario
      • 6.7.5.5. Kuwait hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Market Share Analysis, 2025
  • 7.4. Company Heat Map Analysis
  • 7.5. Strategy Mapping
    • 7.5.1. Expansion
    • 7.5.2. Mergers & Acquisition
    • 7.5.3. Partnerships & Collaborations
    • 7.5.4. New Treatment Type Launches
    • 7.5.5. Research And Development
    • 7.5.6. Company Profiles
    • 7.5.7. Medtronic
      • 7.5.7.1. Company overview
      • 7.5.7.2. Financial performance
      • 7.5.7.3. Treatment Type Benchmarking
      • 7.5.7.4. Strategic initiatives
    • 7.5.8. MicroVention, Inc. (Terumo Corporation)
      • 7.5.8.1. Company overview
      • 7.5.8.2. Financial performance
      • 7.5.8.3. Treatment Type Benchmarking
      • 7.5.8.4. Strategic initiatives
    • 7.5.9. Balt
      • 7.5.9.1. Company overview
      • 7.5.9.2. Financial performance
      • 7.5.9.3. Treatment Type Benchmarking
      • 7.5.9.4. Strategic initiatives
    • 7.5.10. Scientia Vascular, Inc.
      • 7.5.10.1. Company overview
      • 7.5.10.2. Financial performance
      • 7.5.10.3. Treatment Type Benchmarking
      • 7.5.10.4. Strategic initiatives
    • 7.5.11. MicroPort Scientific Corporation
      • 7.5.11.1. Company overview
      • 7.5.11.2. Financial performance
      • 7.5.11.3. Treatment Type Benchmarking
      • 7.5.11.4. Strategic initiatives
    • 7.5.12. Johnson & Johnson (MedTech)
      • 7.5.12.1. Company overview
      • 7.5.12.2. Financial performance
      • 7.5.12.3. Treatment Type Benchmarking
      • 7.5.12.4. Strategic initiatives
    • 7.5.13. phenox GmbH (Wallaby Medical)
      • 7.5.13.1. Company overview
      • 7.5.13.2. Financial performance
      • 7.5.13.3. Treatment Type Benchmarking
      • 7.5.13.4. Strategic initiatives
    • 7.5.14. Acandis GmbH
      • 7.5.14.1. Company overview
      • 7.5.14.2. Financial performance
      • 7.5.14.3. Treatment Type Benchmarking
      • 7.5.14.4. Strategic initiatives
    • 7.5.15. B. Braun SE
      • 7.5.15.1. Company overview
      • 7.5.15.2. Financial performance
      • 7.5.15.3. Treatment Type Benchmarking
      • 7.5.15.4. Strategic initiatives
    • 7.5.16. Integra LifeSciences
      • 7.5.16.1. Company overview
      • 7.5.16.2. Financial performance
      • 7.5.16.3. Treatment Type Benchmarking
      • 7.5.16.4. Strategic initiatives
    • 7.5.17. Infinity Neuro LLC
      • 7.5.17.1. Company overview
      • 7.5.17.2. Financial performance
      • 7.5.17.3. Treatment Type Benchmarking
      • 7.5.17.4. Strategic initiatives
    • 7.5.18. Penumbra, Inc.
      • 7.5.18.1. Company overview
      • 7.5.18.2. Financial performance
      • 7.5.18.3. Treatment Type Benchmarking
      • 7.5.18.4. Strategic initiatives
    • 7.5.19. Boston Scientific Corporation
      • 7.5.19.1. Company overview
      • 7.5.19.2. Financial performance
      • 7.5.19.3. Treatment Type Benchmarking
      • 7.5.19.4. Strategic initiatives
    • 7.5.20. Stryker
      • 7.5.20.1. Company overview
      • 7.5.20.2. Financial performance
      • 7.5.20.3. Treatment Type Benchmarking
      • 7.5.20.4. Strategic initiatives
    • 7.5.21. Peter LAZIC GmbH
      • 7.5.21.1. Company overview
      • 7.5.21.2. Financial performance
      • 7.5.21.3. Treatment Type Benchmarking
      • 7.5.21.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America hemorrhagic stroke treatment devices market, by region, 2021 - 2033 (USD Million)
  • Table 3 North America hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 4 North America hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 5 U.S. hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 6 U.S. hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 7 Canada hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 8 Canada hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 9 Mexico hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 10 Mexico hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 11 Europe hemorrhagic stroke treatment devices market, by region, 2021 - 2033 (USD Million)
  • Table 12 Europe hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 13 Europe hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 14 Germany hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 15 Germany hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 16 UK hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 17 UK hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 18 France hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 19 France hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 20 Italy hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 21 Italy hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 22 Spain hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 23 Spain hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 24 Denmark hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 25 Denmark hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 26 Sweden hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 27 Sweden hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 28 Norway hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 29 Norway hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 30 Asia Pacific hemorrhagic stroke treatment devices market, by region, 2021 - 2033 (USD Million)
  • Table 31 Asia Pacific hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 32 Asia Pacific hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 33 China hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 34 China hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 35 Japan hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 36 Japan hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 37 India hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 38 India hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 39 South Korea hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 40 South Korea hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 41 Australia hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 42 Australia hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 43 Thailand hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 44 Thailand hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 45 Latin America hemorrhagic stroke treatment devices market, by region, 2021 - 2033 (USD Million)
  • Table 46 Latin America hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 47 Latin America hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 48 Brazil hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 49 Brazil hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 50 Argentina hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 51 Argentina hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 52 MEA hemorrhagic stroke treatment devices market, by region, 2021 - 2033 (USD Million)
  • Table 53 MEA hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 54 MEA hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 55 South Africa hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 56 South Africa hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 57 Saudi Arabia hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 58 Saudi Arabia hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 59 UAE hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 60 UAE hemorrhagic stroke treatment devices market, by application, 2021 - 2033 (USD Million)
  • Table 61 UAE hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 62 Kuwait hemorrhagic stroke treatment devices market, by treatment type, 2021 - 2033 (USD Million)
  • Table 63 Kuwait hemorrhagic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Hemorrhagic stroke treatment devices market segmentation.
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Data analysis models
  • Fig. 5 Market formulation and validation
  • Fig. 6 Data validating & publishing.
  • Fig. 7 Market snapshot
  • Fig. 8 Segment snapshot.
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Hemorrhagic stroke treatment devices - market size and growth prospects (USD million)
  • Fig. 11 Hemorrhagic Stroke Treatment Devices Market: Industry Value Chain Analysis
  • Fig. 12 Hemorrhagic Stroke Treatment Devices Market: Market Dynamics
  • Fig. 13 Hemorrhagic Stroke Treatment Devices Market: PORTER's Analysis
  • Fig. 14 Hemorrhagic Stroke Treatment Devices Market: PESTEL Analysis
  • Fig. 15 Hemorrhagic stroke treatment devices market shares by treatment type, 2025 & 2033 (USD Million)
  • Fig. 16 Hemorrhagic stroke treatment devices market, by treatment type: market share, 2023 & 2030
  • Fig. 17 Aneurysm & hemorrhagic stroke interventions market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 18 By indication market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 19 Intracranial aneurysm market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 20 cSDH (MMA Embolization) market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 21 AVM & AVF embolization market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 22 By device market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 23 Embolization coiling systems market share by treatment type, 2025 & 2033 (USD Million)
  • Fig. 24 Bare platinum coils market share by treatment type, 2025 & 2033 (USD Million)
  • Fig. 25 Coated / bioactive coils market share by treatment type, 2025 & 2033 (USD Million)
  • Fig. 26 Flow diversion systems market share by treatment type, 2025 & 2033 (USD Million)
  • Fig. 27 Standard flow-diverting stents (e.g., pipeline) market share by treatment type, 2025 & 2033 (USD Million)
  • Fig. 28 Next-generation / surface-modified flow diverters market share by treatment type, 2025 & 2033 (USD Million)
  • Fig. 29 Intrasaccular flow disruption devices market share by treatment type, 2025 & 2033 (USD Million)
  • Fig. 30 Woven endobridge (WEB) market share by treatment type, 2025 & 2033 (USD Million)
  • Fig. 31 Luna aneurysm embolization system market share by treatment type, 2025 & 2033 (USD Million)
  • Fig. 32 Liquid embolization agents market share by treatment type, 2025 & 2033 (USD Million)
  • Fig. 33 Non-adhesive liquid embolics (onyx, squid, PHIL) market share by treatment type, 2025 & 2033 (USD Million)
  • Fig. 34 Adhesive liquid embolics (NBCA) market share by treatment type, 2025 & 2033 (USD Million)
  • Fig. 35 Cerebral angioplasty & vascular remodeling market share by treatment type, 2025 & 2033 (USD Million)
  • Fig. 36 Vasospasm balloon angioplasty systems market share by treatment type, 2025 & 2033 (USD Million)
  • Fig. 37 Coil-assisted adjunctive devices (balloon-assisted and stent-assisted) market share by treatment type, 2025 & 2033 (USD Million)
  • Fig. 38 Ancillary & procedural access devices market share by treatment type, 2025 & 2033 (USD Million)
  • Fig. 39 Guiding & distal access catheters market share by treatment type, 2025 & 2033 (USD Million)
  • Fig. 40 Microcatheters market share by treatment type, 2025 & 2033 (USD Million)
  • Fig. 41 Access sheaths & wires market share by treatment type, 2025 & 2033 (USD Million)
  • Fig. 42 Hemorrhagic stroke treatment devices market share by end use, 2025 & 2033 (USD Million)
  • Fig. 43 Hemorrhagic stroke treatment devices market, by end use: market share, 2023 & 2030.
  • Fig. 44 Hospitals market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 45 Specialty neurosurgery centers market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 46 Ambulatory surgical centers market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 47 Regional marketplace: key takeaways
  • Fig. 48 North America hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 U.S. hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Canada hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Mexico hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Europe hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 UK hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Germany hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 France hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Italy hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Spain hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Sweden hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Denmark hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Norway hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Asia Pacific hemorrhagic stroke treatment devices market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 62 China hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Japan hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 India hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 South Korea hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Australia hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Thailand hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Latin America hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Brazil hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Argentina hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 MEA hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 South Africa hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 Saudi Arabia hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 UAE hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 Kuwait hemorrhagic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Key company categorization
  • Fig. 77 Company market positioning
  • Fig. 78 Key company market share analysis, 2025
  • Fig. 79 Strategic framework